GSK’s Gonorrhoea Drug Achieves Main Goal in Late-stage Trial

GSK’s Gonorrhoea Drug Achieves Main Goal in Late-stage Trial

British pharmaceutical company GSK announced on Monday that its oral drug for treating gonorrhea, called gepotidacin, has met the primary…